Falling Oil Prices Drive Indian Stocks to 7-Month Winning Streak

Indian equity markets have achieved their longest weekly winning streak in seven months, bolstered by a significant decline in crude oil prices and proactive central bank measures. The Nifty 50 and BSE Sensex extended their gains on Thursday, reflecting growing investor confidence in the domestic economic outlook.

Crude Oil Slide Eases Inflationary Pressure

A major catalyst for the recent market rally is the cooling of global crude oil prices. Brent crude fell by 1.4% to settle at $72.7 per barrel, returning to levels seen prior to the Iran-war tensions. This decline was driven by increased tanker movement exiting the Strait of Hormuz following a U.S.-Iran peace deal.

For India, the world's third-largest oil importer, lower crude prices are a massive relief. Reduced oil costs help mitigate growth and inflation concerns, directly benefiting sectors with high fuel dependency. Notably, Interglobe Aviation saw its stock climb 8.5% as investors reacted to the easing of cost concerns for the airline industry.

Policy Support and Currency Stability

Beyond energy prices, domestic policy shifts have provided a significant tailwind for the markets. Recent measures aimed at supporting the rupee and attracting overseas capital inflows have boosted sentiment. The Reserve Bank of India (RBI) has played a crucial role, with Governor Sanjay Malhotra ruling out any near-term interest rate hikes. Lower borrowing costs are expected to support corporate earnings, consumer spending, and overall market valuations.

Furthermore, the RBI’s decision to allow loans against foreign-currency deposits has bolstered the financial sector. Heavyweight financials, banks, and private lenders rose by 1.3%, 0.9%, and 1.5%, respectively, over the week. Additionally, the government's removal of bond taxes for foreign investors is expected to drive further inflows into the Indian market.

Sectoral Performance and Risk Factors

The market rally was not uniform across all sectors. While six of the 16 major sectors posted weekly gains, the mid-cap segment faced some headwinds, falling 1.2%.

The Pharma index emerged as a standout performer, gaining 2.1% this week. This surge was fueled by reports of the U.S. FDA engaging with Indian drugmakers regarding a critical cancer drug. Analysts noted that investors are rotating into sectors like healthcare and pharma that are less exposed to volatile crude oil prices and El Niño-related risks. Conversely, the Metals sector logged a significant weekly loss of 4.4%, tracking weaker global prices amid rising expectations of U.S. rate hikes in 2026.

Despite the optimism, analysts warn that a below-normal monsoon remains a near-term risk that could impact domestic consumption and rural demand.

Key Takeaways

  • Extended Winning Streak: Indian benchmarks achieved their longest weekly winning run in seven months, with the Nifty 50 and Sensex posting weekly advances of 0.2% and 0.4%, respectively.
  • Energy as a Catalyst: The drop in Brent crude to $72.7 per barrel has eased inflation concerns and boosted aviation stocks like Interglobe Aviation.
  • Policy Tailwinds: RBI's stance against near-term rate hikes and new measures to mobilize foreign-currency deposits are driving institutional inflows and supporting the financial sector.